<?xml version="1.0" encoding="UTF-8"?>
<fig id="ppat.1006932.g001" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.ppat.1006932.g001</object-id>
 <label>Fig 1</label>
 <caption>
  <p>(A) Role of Evola virus (EBOV) glycoprotein (GP) steric shielding in impairment of T-cell response. Comparison between a typical viral infection and EBOV infection and the role of EBOV GP overexpression on cell surface membrane. (B) Role of EBOV VP35 interferon-inhibiting domain (IID) in suppression and dysregulation of cell-mediated response. Effects of wild-type (wt) EBOV (left) and the mutated virus with VP35 IID disabled by amino acid substitution R312A on dendritic cells (DCs), natural killer (NK) cells, B cells, and T cells. Summarized from references [
   <xref rid="ppat.1006932.ref020" ref-type="bibr">20</xref>, 
   <xref rid="ppat.1006932.ref023" ref-type="bibr">23</xref>, 
   <xref rid="ppat.1006932.ref024" ref-type="bibr">24</xref>]. APC, antigen-presenting cells; CD-80, -86, cluster of differentiation; VP35, viral protein 35.
  </p>
 </caption>
 <graphic xlink:href="ppat.1006932.g001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
